These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 33959860)

  • 41. [Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes].
    Lu FM; Tong ZL; Mao YM; Wu DY; Xu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):478-81. PubMed ID: 22875511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.
    Sorich MJ; Rowland A; McKinnon RA; Wiese MD
    Circ Cardiovasc Genet; 2014 Dec; 7(6):895-902. PubMed ID: 25258374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population.
    Xie X; Ma YT; Yang YN; Li XM; Ma X; Fu ZY; Zheng YY; Chen BD; Liu F
    PLoS One; 2013; 8(3):e59344. PubMed ID: 23555019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study.
    Chang CJ; Tung YC; Liu JR; Chang SH; Kuo CT; See LC
    Clin Pharmacol Ther; 2021 Feb; 109(2):443-451. PubMed ID: 32767756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
    J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
    Bhurke SM; Martin BC; Li C; Franks AM; Bursac Z; Said Q
    Pharmacotherapy; 2012 Sep; 32(9):809-18. PubMed ID: 22744772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
    Zou D; Goh KL
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1152-1159. PubMed ID: 28024166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
    Zhang L; Chen Y; Jin Y; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Li X; Li Y; Zhang Y; Lu C; Yin T
    Thromb Res; 2013 Jul; 132(1):81-7. PubMed ID: 23726091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
    Gurbel PA; Lau WC; Tantry US
    J Am Coll Cardiol; 2008 Jan; 51(3):261-3. PubMed ID: 18206733
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of drug interaction between clopidogrel and omeprazole in hospital readmision of patients by a recurrent acute coronary syndrome: a case-control study].
    Amariles P; Holguín H; Angulo NY; Betancourth PM; Ceballos M
    Aten Primaria; 2014 Oct; 46(8):426-32. PubMed ID: 24581893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.
    Cresci S; Depta JP; Lenzini PA; Li AY; Lanfear DE; Province MA; Spertus JA; Bach RG
    Circ Cardiovasc Genet; 2014 Jun; 7(3):277-86. PubMed ID: 24762860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study.
    Lin J; Mo Y; Cai D; Mao D; Fu H; Wei D
    Ann Palliat Med; 2021 Dec; 10(12):12171-12180. PubMed ID: 35016407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Frequency of the Minor Polymorphisms in the
    Zelenskaya EM; Lifshits GI; Nikolaev KY; Donirova OS; Altayev VD; Apartsin KA; Voronina EN; Protasov KV; Sychev DA
    Genet Test Mol Biomarkers; 2020 Jun; 24(6):338-342. PubMed ID: 32392440
    [No Abstract]   [Full Text] [Related]  

  • 57. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina.
    Kim HS; Chang K; Koh YS; Park MW; Choi YS; Park CS; Oh M; Kim EY; Shon JH; Shin JG; Seung KB
    Circ Cardiovasc Genet; 2013 Oct; 6(5):514-21. PubMed ID: 24019397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.
    Giorgi MA; Di Girolamo G; González CD
    Expert Opin Pharmacother; 2010 Oct; 11(14):2391-403. PubMed ID: 20828266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.
    Collet JP; Hulot JS; Pena A; Villard E; Esteve JB; Silvain J; Payot L; Brugier D; Cayla G; Beygui F; Bensimon G; Funck-Brentano C; Montalescot G
    Lancet; 2009 Jan; 373(9660):309-17. PubMed ID: 19108880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.